CriteriaCaixa reboosts its investment business in science and technology -based startups 17/07/2026 Healthcare Innovative drugs Financing Caixa Capital Risc, a CriteriaCaixa venture capital management company, rebrands to Criteria Capital Risc. Partners - CRITERIA BIO VENTURES
#BIOSPAIN2026 | Encapsulation technologies: Driving the next generation of therapies 22/07/2026 Healthcare Personalized medicine International BioSpain The future of medicine will depend not only on discovering new drugs, but also on developing technologies capable of... AseBio
#BIOSPAIN 2026 | Galicia Bio: A Bioregion ready to compete, attract investment and lead th... 20/07/2026 Healthcare Industrial biotechnology Bioeconomy International BioSpain Román Rodríguez González, Regional Minister for Education, Science, Universities and Vocational Training of the Xunta de... AseBio
#BIOSPAIN 2026 | ABIOINNOVA: A new engine for transforming science into companies that wil... 14/07/2026 Healthcare BioSpain Financing BIOSPAIN 2026 will provide the stage for Castilla y León to unveil a new approach to driving innovation in the life... Partners - AYUNTAMIENTO DE SALAMANCA
AseBio welcomes progress in the european reform of genetically modified microorganism legi... 13/07/2026 Healthcare Agrifood Food & feed Agriculture AseBio believes the reform is moving in the right direction, while calling for regulatory ambition to be maintained... AseBio
AseBio welcomes progress in the european reform of genetically modified microorganism legi... 13/07/2026 The European regulatory framework for genetically modified microorganisms (GMMs) is undergoing an update to keep pace... AseBio
What do the Catalan healthcare startups that raised the most funding in 2025 have in com... 10/07/2026 Healthcare Financing Communication The largest funding rounds of 2025 were concentrated in companies that combine an unmet need, solid evidence, and the... Partners - GENESIS Biomed
ORYZON announces U.S. patent grant for vafidemstat in borderline personality disorder (BP... 08/07/2026 Healthcare Rare diseases Innovative drugs Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD. Partners - Oryzon Genomics
Zoonotic diseases highlight the need to strengthen prevention and the One Health approach ... 06/07/2026 Healthcare Climate change Animal health Industrial biotechnology On World Zoonoses Day, we spoke with HIPRA, one of the European biotechnology companies most strongly committed to the... AseBio - HIPRA HUMAN HEALTH S.L.U.
Zoonotic diseases highlight the need to strengthen prevention and the One Health approach ... 06/07/2026 HIPRA HUMAN HEALTH S.L.U. Around 60% of human infectious diseases originate in animals. Climate change and globalization are reinforcing the need... AseBio - HIPRA HUMAN HEALTH S.L.U.
